Canadian Sec - Delayed Quote USD

Cansortium Inc. (TIUM-U.CN)

Compare
0.0700
-0.0025
(-3.45%)
At close: January 24 at 3:59:39 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. William M. Smith Executive Chairman 175k -- --
Mr. Robert Beasley CEO & Director 616.67k -- --
Ms. Patricia Fonseca CFO & Corporate Secretary 36.23k -- --
Ms. Samantha Senne Hymes Executive Vice President of Operations 261.49k -- --
Mr. Victor Bindi Director of Sales 230.6k -- --
Ms. Liora Boudin Corporate Controller 560.62k -- --
Dr. Jennifer McCafferty-Fernandez Chief Science Officer -- -- --
Mr. Jeffrey Reath Consultant 197.9k -- --

Cansortium Inc.

5540 West Executive Drive
Suite 100
Tampa, FL 33609
United States
305 902 2720 https://getfluent.com
Sector: 
Healthcare

Description

Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, and edibles under the Fluent brand name. It also sells various third-party branded medical cannabis products. The company was incorporated in 2018 and is headquartered in Tampa, Florida.

Corporate Governance

Cansortium Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 29, 2024 at 9:05 PM UTC

Cansortium Inc. Earnings Date

Recent Events

Related Tickers